FBRX
$1.02
Forte Biosciences
$.02
2.27%
FBRX
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.00
Revenue:  N/A
Monday
Aug 14
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when FBRX reports earnings?
Beat
Meet
Miss

Where is FBRX's stock price going from here?
Up
Flat
Down
Stock chart of FBRX
Analysts
Summary of analysts' recommendations for FBRX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.
›